User login
Key clinical point: A significant proportion of patients with atopic dermatitis (AD) experience sleep disturbance (SD), which usually improves overtime; however, patients with moderate-to-severe AD are more likely to experience a persistent SD course.
Major finding: At least 3 nights of SD were reported by 34.2% of patients at baseline; however only 12.3% of patients reported persistent SD at the first and second follow-ups, and only 11.5% of patients with severe SD at baseline experienced persistent SD scores at the second follow-up. Severe/very severe AD vs. mild AD was a significant predictor of increased nights of SD by eczema (adjusted odds ratio 16.20; P < .0001).
Study details: This prospective, dermatology practice-based study included 1,295 patients with mild (40.5%), moderate (35.1%), or severe/very severe (24.4%) AD.
Disclosures: This study was supported by the Agency for Healthcare Research and Quality, the Dermatology Foundation, and an unrestricted research grant from Galderma. R Chavda and S Gabriel declared being employees of and JI Silverberg declared being a consultant for Galderma.
Source: Manjunath J et al. longitudinal course of sleep disturbance and relationship with itch in adult atopic dermatitis in clinical practice. Dermatitis. 2022 (Mar 3). Doi: 10.1097/DER.0000000000000859
Key clinical point: A significant proportion of patients with atopic dermatitis (AD) experience sleep disturbance (SD), which usually improves overtime; however, patients with moderate-to-severe AD are more likely to experience a persistent SD course.
Major finding: At least 3 nights of SD were reported by 34.2% of patients at baseline; however only 12.3% of patients reported persistent SD at the first and second follow-ups, and only 11.5% of patients with severe SD at baseline experienced persistent SD scores at the second follow-up. Severe/very severe AD vs. mild AD was a significant predictor of increased nights of SD by eczema (adjusted odds ratio 16.20; P < .0001).
Study details: This prospective, dermatology practice-based study included 1,295 patients with mild (40.5%), moderate (35.1%), or severe/very severe (24.4%) AD.
Disclosures: This study was supported by the Agency for Healthcare Research and Quality, the Dermatology Foundation, and an unrestricted research grant from Galderma. R Chavda and S Gabriel declared being employees of and JI Silverberg declared being a consultant for Galderma.
Source: Manjunath J et al. longitudinal course of sleep disturbance and relationship with itch in adult atopic dermatitis in clinical practice. Dermatitis. 2022 (Mar 3). Doi: 10.1097/DER.0000000000000859
Key clinical point: A significant proportion of patients with atopic dermatitis (AD) experience sleep disturbance (SD), which usually improves overtime; however, patients with moderate-to-severe AD are more likely to experience a persistent SD course.
Major finding: At least 3 nights of SD were reported by 34.2% of patients at baseline; however only 12.3% of patients reported persistent SD at the first and second follow-ups, and only 11.5% of patients with severe SD at baseline experienced persistent SD scores at the second follow-up. Severe/very severe AD vs. mild AD was a significant predictor of increased nights of SD by eczema (adjusted odds ratio 16.20; P < .0001).
Study details: This prospective, dermatology practice-based study included 1,295 patients with mild (40.5%), moderate (35.1%), or severe/very severe (24.4%) AD.
Disclosures: This study was supported by the Agency for Healthcare Research and Quality, the Dermatology Foundation, and an unrestricted research grant from Galderma. R Chavda and S Gabriel declared being employees of and JI Silverberg declared being a consultant for Galderma.
Source: Manjunath J et al. longitudinal course of sleep disturbance and relationship with itch in adult atopic dermatitis in clinical practice. Dermatitis. 2022 (Mar 3). Doi: 10.1097/DER.0000000000000859